Serina Therapeutics, Inc. ($SER)
Filing Information
| Accession Number | 0001301120-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
19,500
Total Value
$20,070.05
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Feb 2, 2026 | Exercise/Conversion | 6,500 | $0.06 | $390.00 | 6,500 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Feb 2, 2026 | Sale | 6,500 | $3.03 | $19,680.05 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Feb 2, 2026 | Exercise/Conversion | 6,500 | $0.00 | $0.00 | 313,186 | Direct | โ | View Details |